Erythropoietin as an antiapoptotic, tissue-protective cytokine
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Erythropoietin (EPO) increases the number of circulating erythrocytes primarily by preventing apoptosis of erythroid progenitors. In addition to this proerythroid action, results of recent studies show that systemically administered EPO is protective in vivo, in several animal models of neuronal injury. In vitro, EPO prevents neuronal apoptosis induced by a variety of stimuli. This review summarizes the neuroprotective actions of EPO and discusses the underlying mechanisms in terms of signal transduction pathways involved. The understanding of these mechanisms will help differentiate the neuroprotective actions of EPO from its role in the bone marrow.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Erythropoietin was originally recognized via its role in erythropoiesis [2145-2147] (hence its name, of course), but it has become evident that it has many other roles, and in particular it is observed phenomenologically that erythropoietin (and non-erthyropoetic derivatives) is protective in a number of inflammatory conditions that accompany many diseases such as those listed above [940,942,2148-”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2149]
Citations
Cites
Structural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069 · cited 1×
“cytokines of the IL-6 family (IL-6, leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF) and oncostatin M).(21,22)”
BackgroundNF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402
Self-citationVEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A. V., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17977 · Cited by 1,282
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317977 · Cited by 1,189
Wenger, R. H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0944rev · Cited by 1,135 · cited 1×
“been suggested that, because HIF is often constitutively expressed in tumors, it may mediate the high constitutive expression of glycolytic enzymes that is the basis of the Warburg effect.(3,5)”
BackgroundErythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H.-H., Breiter, N., Jacob, S., Knerlich, F., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402029 · Cited by 1,028 · cited 1×
“of human stroke by EPO used three daily doses substantially higher than the clinical norm and, in these patients, EPO was shown to be safe and did not raise the hemoglobin concentration.(80) Thus, this might represent a valuable therapeutic approach to acute CNS injury, such as brain and spinal cord trauma.”
Self-citationErythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019 · cited 3×
“Using a model of ischemia with reperfusion, it was shown that neurons within the penumbra would undergo apoptosis unless exposed to EPO within 3 h of injury.(39) In addition to this antiapoptotic effect, EPO administration is also associated with a marked decrease in proinflammatory cytokines within the hemisphere und…”
BackgroundMethodInfluentialSelf-citationOosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Dorpe, J. V., Hellings, P., Gorselink, M., Heymans, S., et al. (2001) · Nature Genetics · doi:10.1038/88842 · Cited by 1,007
In vivo evidence that erythropoietin protects neurons from ischemic damage
Sakanaka, M., Wen, T.-C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M., & Sasaki, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4635 · Cited by 949
Digicaylioglu, M., & Lipton, S. A. (2001) · Nature · doi:10.1038/35088074 · Cited by 923
Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S. L., Wyns, S., Thijs, V., Andersson, J., van Marion, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1211 · Cited by 860
Erythropoietin Retards DNA Breakdown and Prevents Programmed Death in Erythroid Progenitor Cells
Koury, M. J., & Bondurant, M. C. (1990) · Science · doi:10.1126/science.2326648 · Cited by 812 · cited 1×
“erythroid progenitors is thought to be a major mechanism in EPO action.(17,18)”
BackgroundA Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice
Bernaudin, M., Marti, H. H., Roussel, S., Divoux, D., Nouvelot, A., MacKenzie, E. T., & Petit, E. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199906000-00007 · Cited by 715 · cited 1×
“rally, EPOR upregulation occurs first by 12 h, primarily in neurons and endothelial cells of the microcirculation, followed hours later by an increase in EPO by both astrocytes and neurons.(31) These effects are especially prominent in the Table 1 Neuroprotective effects of EPO in vitro (selected references)”
BackgroundFetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice
Socolovsky, M., Fallon, A. E. J., Wang, S., Brugnara, C., & Lodish, H. F. (1999) · Cell · doi:10.1016/s0092-8674(00)81013-2 · Cited by 696 · cited 1×
“knockout mice, possibly due to a disruption of the Bcl-xL response pathway.(26) Further, EPOR activation activates voltage-sensitive Ca2þ channels, which in turn modulates neurotransmitter.”
Human CD14 mediates recognition and phagocytosis of apoptotic cells
Devitt, A., Moffatt, O. D., Raykundalia, C., Capra, J. D., Simmons, D. L., & Gregory, C. D. (1998) · Nature · doi:10.1038/33169 · Cited by 681 · cited 1×
“dying that triggers much less inflammation than by necrosis, and this is certainly true in many experimental models.(47,48) However, this model of ‘docking without shocking’,(49) may not apply to all pathological conditions, and production of”
BackgroundMorishita, E., Masuda, S., Nagao, M., Yasuda, Y., & Sasaki, R. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00306-5 · Cited by 661
Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells
Seagroves, T. N., Ryan, H. E., Lu, H., Wouters, B. G., Knapp, M., Thibault, P., Laderoute, K., & Johnson, R. S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3436-3444.2001 · Cited by 634 · cited 1×
“metabolic, cell-autonomous adaptation to hypoxia represented by the switch of ATP generation from oxidative phosphorylation to glycolysis, the Pasteur effect.(4) It has also”
BackgroundCalvillo, L., Latini, R., Kajstura, J., Leri, A., Anversa, P., Ghezzi, P., Salio, M., Cerami, A., & Brines, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630444100 · Cited by 611 · cited 3×
“EPO has been shown to be protective of myocardial ischemia either permanent or with reperfusion.(12,71) Further,”
BackgroundSelf-citationCrystallographic Evidence for Preformed Dimers of Erythropoietin Receptor Before Ligand Activation
Livnah, O., Stura, E. A., Middleton, S. A., Johnson, D. L., Jolliffe, L. K., & Wilson, I. A. (1999) · Science · doi:10.1126/science.283.5404.987 · Cited by 599
Cai, Z., Manalo, D. J., Wei, G., Rodriguez, E. R., Fox-Talbot, K., Lu, H., Zweier, J. L., & Semenza, G. L. (2003) · Circulation · doi:10.1161/01.cir.0000078635.89229.8a · Cited by 557 · cited 1×
“Further, studies performed on isolated hearts have shown that EPO mediates ischemic preconditioning.(72)”
BackgroundBazan, J. F. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91528-3 · Cited by 546 · cited 1×
“cytokines of the IL-6 family (IL-6, leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF) and oncostatin M).(21,22)”
BackgroundVilla, P., Bigini, P., Mennini, T., Agnello, D., Laragione, T., Cagnotto, A., Viviani, B., Marinovich, M., Cerami, A., Coleman, T. R., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021067 · Cited by 527 · cited 5×
“In fact, neurons exposed to trimethyltin, a toxin that induces neuronal apoptosis,45 release as yet unidentified factors that stimulate inflammatory TNF production by glial cells that, in turn, amplifies neurotoxicity.46 In this context, EPO inhibits TNF production by TMT-exposed neuron-glia co-cultures but not by pur…”
BackgroundMethodInfluentialSelf-citationCelik, M., Gökmen, N., Erbayraktar, S., Akhisaroglu, M., Konakç, S., Ulukus, C., Genc, S., Genc, K., Sagiroglu, E., Cerami, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042693799 · Cited by 473
Self-citationKupffer Cell Engulfment of Apoptotic Bodies Stimulates Death Ligand and Cytokine Expression
Canbay, A., Feldstein, A. E., Higuchi, H., Werneburg, N., Grambihler, A., Bronk, S. F., & Gores, G. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50472 · Cited by 470 · cited 1×
“inflammatory cytokines by tissue macrophages during phagocytosis of apoptotic cells.(50,51) Similarly to what is observed in a model of cerebral ischemia with EPO,(40) inhibition of”
BackgroundRuscher, K., Freyer, D., Karsch, M., Isaev, N., Megow, D., Sawitzki, B., Priller, J., Dirnagl, U., & Meisel, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10291.2002 · Cited by 462 · cited 2×
“On the other hand, unlike others reported in erythroid cells, the other pathway downstream of Jak2, activation of STATs, was not activated by EPO in this study, and no induction of mRNA for Bcl2, Bcl-xL, Bag-1, Bax or Bad, was observed, as measured by PCR.(61)”
BackgroundAsialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo
Erbayraktar, S., Grasso, G., Sfacteria, A., Xie, Q.-W., Coleman, T., Kreilgaard, M., Torup, L., Sager, T., Erbayraktar, Z., Gokmen, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031753100 · Cited by 436
Self-citationMasuda, S., Nagao, M., Takahata, K., Konishi, Y., Gallyas, F., Tabira, T., & Sasaki, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82112-3 · Cited by 421
Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury
Junk, A. K., Mammis, A., Savitz, S. I., Singh, M., Roth, S., Malhotra, S., Rosenbaum, P. S., Cerami, A., Brines, M., & Rosenbaum, D. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152321399 · Cited by 415
Self-citationGorio, A., Gokmen, N., Erbayraktar, S., Yilmaz, O., Madaschi, L., Cichetti, C., Di Giulio, A. M., Vardar, E., Cerami, A., & Brines, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142287899 · Cited by 389
Self-citationChong, Z. Z., Kang, J.-Q., & Maiese, K. (2002) · Circulation · doi:10.1161/01.cir.0000039103.58920.1f · Cited by 381
Minchenko, A., Leshchinsky, I., Opentanova, I., Sang, N., Srinivas, V., Armstead, V., & Caro, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110978200 · Cited by 370
Erythropoietin receptor signalling is required for normal brain development
Yu, X., Shacka, J. J., Eells, J. B., Suarez-Quian, C., Przygodzki, R. M., Beleslin-Cokic, B., Lin, C.-S., Nikodem, V. M., Hempstead, B., Flanders, K. C., et al. (2002) · Development · doi:10.1242/dev.129.2.505 · Cited by 367
Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain
Sirén, A.-L., Knerlich, F., Poser, W., Gleiter, C. H., Brück, W., & Ehrenreich, H. (2001) · Acta Neuropathologica · doi:10.1007/s004010000297 · Cited by 349 · cited 1×
“normal brain expresses both EPO and EPOR in a highly restricted and limited manner, following ischemic and other stressors a marked induction of both proteins occurs in animal models(31) as well as in human disease.(32,33) Presumably, this regulation is accomplished by specific proinflammatory cytokines, for example,…”
BackgroundSilva, M., Grillot, D., Benito, A., Richard, C., Nunez, G., & Fernandez-Luna, J. (1996) · Blood · doi:10.1182/blood.v88.5.1576.1576 · Cited by 343
Agnello, D., Bigini, P., Villa, P., Mennini, T., Cerami, A., Brines, M. L., & Ghezzi, P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03239-0 · Cited by 334 · cited 1×
“the CNS of autoimmune origin with marked inflammation in the almost complete absence of neuronal death, at least in the earliest times of the disease.(54) Thus, it cannot be ruled out that EPO exerts an anti-inflammatory action on the CNS by”
BackgroundSelf-citationThe phosphatidylserine receptor: a crucial molecular switch?
Henson, P. M., Bratton, D. L., & Fadok, V. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085094 · Cited by 321 · cited 1×
“dying that triggers much less inflammation than by necrosis, and this is certainly true in many experimental models.(47,48) However, this model of ‘docking without shocking’,(49) may not apply to all pathological conditions, and production of”
BackgroundZaman, K., Ryu, H., Hall, D., O'Donovan, K., Lin, K.-I., Miller, M. P., Marquis, J. C., Baraban, J. M., Semenza, G. L., & Ratan, R. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-22-09821.1999 · Cited by 320 · cited 1×
“Activation of HIF and/or pre-exposure to hypoxia also protects neuronal cells from apoptosis induced by oxidative stress.(6)”
BackgroundErythropoietin and VEGF Exhibit Equal Angiogenic Potential
Jaquet, K., Krause, K., Tawakol-Khodai, M., Geidel, S., & Kuck, K.-H. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2426 · Cited by 317 · cited 3×
“The induction of glycolytic enzymes demonstrates a role for HIF in the metabolic, cell-autonomous adaptation to hypoxia represented by the switch of ATP generation from oxidative phosphorylation to glycolysis, the Pasteur effect.4 It has also been suggested that, because HIF is often constitutively expressed in tumors…”
BackgroundNagai, A., Nakagawa, E., Choi, H. B., Hatori, K., Kobayashi, S., & Kim, S. U. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.4.386 · Cited by 306 · cited 2×
“Multiple studies have shown that whereas normal brain expresses both EPO and EPOR in a highly restricted and limited manner, following ischemic and other stressors a marked induction of both proteins occurs in animal models31 as well as in human disease.32,33 Presumably, this regulation is accomplished by specific pro…”
BackgroundMoon, C., Krawczyk, M., Ahn, D., Ahmet, I., Paik, D., Lakatta, E. G., & Talan, M. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1930406100 · Cited by 301 · cited 1×
“EPO has been shown to be protective of myocardial ischemia either permanent or with reperfusion.(12,71) Further,”
BackgroundErythropoietin protects against ischaemic acute renal injury
Vesey, D. A. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg547 · Cited by 286 · cited 1×
“In ischemic injury with reperfusion, EPO prevents apoptosis of tubular epithelial cells as well as mediates intense mitotic activity of the surviving population of proximal tubular epithelial cells.(73)”
BackgroundSilva, M., Benito, A., Sanz, C., Prosper, F., Ekhterae, D., Nuñez, G., & Fernandez-Luna, J. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22165 · Cited by 277
Kawakami, M., Sekiguchi, M., Sato, K., Kozaki, S., & Takahashi, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105832200 · Cited by 251 · cited 1×
“Further, EPOR activation activates voltage-sensitive Ca2þ channels, which in turn modulates neurotransmitter.(27)”
BackgroundErythropoietin both protects from and reverses experimental diabetic neuropathy
Bianchi, R., Buyukakilli, B., Brines, M., Savino, C., Cavaletti, G., Oggioni, N., Lauria, G., Borgna, M., Lombardi, R., Cimen, B., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307823100 · Cited by 248
Self-citationPhagocytic docking without shocking
Savill, J. (1998) · Nature · doi:10.1038/33025 · Cited by 237
Chong, Z. Z., Kang, J., & Maiese, K. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705161 · Cited by 237 · cited 1×
“The marked in vivo reduction of recruitment of microglia into the region of injury is likely explained by the reduced expression of cell surface markers of apoptosis, for example, phosphatidylserine.(41) It should be noted that this proinflammatory role of phosphatidylserine conflicts with other works showing that it…”
BackgroundYang, C. W., Li, C., Young Jung, J., Shin, S. J., Choi, B. S., Lim, S. W., Sun, B. K., Kim, Y. S., Kim, J., Chang, Y. S., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-1191fje · Cited by 237
Signal Transduction in the Erythropoietin Receptor System
Wojchowski, D. M., Gregory, R. C., Miller, C. P., Pandit, A. K., & Pircher, T. J. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4673 · Cited by 225 · cited 2×
“Other members include receptors for IL-2 beta chain, IL-3, IL-4, IL-5, G-CSF, GM-CSF, thrombopoietin, growth hormone, prolactin and the receptors for several cytokines of the IL-6 family (IL-6, leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF) and oncostatin M).21,22 One possible signal transduction…”
BackgroundSuzuki, N., Ohneda, O., Takahashi, S., Higuchi, M., Mukai, H. Y., Nakahata, T., Imagawa, S., & Yamamoto, M. (2002) · Blood · doi:10.1182/blood-2002-01-0124 · Cited by 215 · cited 1×
“them from lethality suggesting that nonhematopoietic EPOR is not essential for development.(38) It would be interesting to”
BackgroundBrouckaert, G., Kalai, M., Krysko, D. V., Saelens, X., Vercammen, D., Ndlovu, `., Haegeman, G., D'Herde, K., & Vandenabeele, P. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0668 · Cited by 209
Erythropoietin: a candidate compound for neuroprotection in schizophrenia
Ehrenreich, H., Degner, D., Meller, J., Brines, M., Béhé, M., Hasselblatt, M., Woldt, H., Falkai, P., Knerlich, F., Jacob, S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001442 · Cited by 208
Self-citationWagner, K.-U., Claudio, E., Rucker, E. B., Riedlinger, G., Broussard, C., Schwartzberg, P. L., Siebenlist, U., & Hennighausen, L. (2000) · Development · doi:10.1242/dev.127.22.4949 · Cited by 205
Chong, Z. Z., Kang, J.-Q., & Maiese, K. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200205000-00001 · Cited by 200 · cited 1×
“The antiapoptotic action of NF-kB in neurons also involves activation of Akt1 and Bad phosphorylation(41,61) as well as Bcl-xL upregulation.(62,63)”
BackgroundImmunohistochemical Localization of Erythropoietin and Its Receptor in the Developing Human Brain
Juul, S. E., Yachnis, A. T., Rojiani, A. M., & Christensen, R. D. (1999) · Pediatric and Developmental Pathology · doi:10.1007/s100249900103 · Cited by 198
Sugawa, M., Sakurai, Y., Ishikawa-Ieda, Y., Suzuki, H., & Asou, H. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00161-x · Cited by 197
Rabuffetti, M., Sciorati, C., Tarozzo, G., Clementi, E., Manfredi, A. A., & Beltramo, M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04398.2000 · Cited by 196 · cited 1×
“apoptosis by lysophosphatidic acid or caspase inhibitors decreases inflammation in models of ischemic injury in the kidney and the brain.(52,53)”
BackgroundMaintenance by erythropoietin of viability and maturation of murine erythroid precursor cells
Koury, M. J., & Bondurant, M. C. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041370108 · Cited by 193 · cited 1×
“survival and therefore enabling the proliferation and differentiation of erythroid progenitor cells.(13,14) Although EPO, through the EPOR, can effectively support the proliferation of murine erythroid progenitor cells ex vivo(15) and induce the entry of erythroid progenitors into cell cycle if dormant,(16)”
BackgroundEffects of Erythropoietin on Neuronal Activity
Koshimura, K., Murakami, Y., Sohmiya, M., Tanaka, J., & Kato, Y. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722565.x · Cited by 185
Wen, T., Sadamoto, Y., Tanaka, J., Zhu, P., Nakata, K., Ma, Y., Hata, R., & Sakanaka, M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10166 · Cited by 184 · cited 2×
“Bcl-xL was also found induced by EPO in a study where DNA microarrays were used to identify modulated genes in PC12 neuronal-like cells(64) and in vivo in a gerbil model of cerebral ischemia.(62) Of note, Ruscher et al.”
BackgroundErythropoietin protects the in vitro blood–brain barrier against VEGF‐induced permeability
Martínez‐Estrada, O. M., Rodríguez‐Millán, E., González‐de Vicente, E., Reina, M., Vilaró, S., & Fabre, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02987.x · Cited by 161
Kashii, Y., Uchida, M., Kirito, K., Tanaka, M., Nishijima, K., Toshima, M., Ando, T., Koizumi, K., Endoh, T., Sawada, K.-I., et al. (2000) · Blood · doi:10.1182/blood.v96.3.941 · Cited by 159
Neuroprotective Effect of Erythropoietin on Hypoxic-Ischemic Brain Injury in Neonatal Rats
Kumral, A., Ozer, E., Yilmaz, O., Akhisaroglu, M., Gokmen, N., Duman, N., Ulukus, C., Genc, S., & Ozkan, H. (2003) · Neonatology · doi:10.1159/000068926 · Cited by 159
Campana, W. M., & Myers, R. R. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02875.x · Cited by 156
Erythropoietin is both a mitogen and a survival factor
Spivak, J., Pham, T., Isaacs, M., & Hankins, W. (1991) · Blood · doi:10.1182/blood.v77.6.1228.1228 · Cited by 154
Genç, Ş., Akhisaroğlu, M., Kuralay, F., & Genç, K. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00041-1 · Cited by 142 · cited 1×
“manner ameliorates neuronal damage caused by excitotoxins.(58) EPO also promotes the differentiation and maturation of astrocytes and oligodendrocytes and directly induces the proliferation of astrocytes,(59) actions that can modify potential Figure 1 Summary of demonstrated EPO-signaling pathways in neuronal protecti…”
BackgroundDzietko, M., Felderhoff-Mueser, U., Sifringer, M., Krutz, B., Bittigau, P., Thor, F., Heumann, R., Bührer, C., Ikonomidou, C., & Hansen, H. H. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.10.006 · Cited by 139 · cited 3×
“In fact, PI(3)K is activated by EPO in the EPO-dependent UT-7 leukemia cell line, where it recruits Akt.28 This PI3K–Akt pathway also leads to upregulation of Bcl-xL and inhibition of apoptosis in Baf-3 cells.29 A further mechanism could be represented by NF-kB that is also a target of the PI3K-Akt pathway and mediate…”
BackgroundGenç, Ş., Kuralay, F., Genç, K., Akhisaroğlu, M., Fadiloglu, S., Yörükoğlu, K., Fadıloğlu, M., & Güre, A. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01716-x · Cited by 132
Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity
Sinor, A. D., & Greenberg, D. A. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01361-6 · Cited by 131
Erythropoietin enhances recovery after cisplatin‐induced acute renal failure in the rat
Bagnis, C., Beaufils, H., Jacquiaud, C., Adabra, Y., Jouanneau, C., Le Nahour, G., Jaudon, M. C., Bourbouze, R., Jacobs, C., & Deray, G. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.5.932 · Cited by 130
Glia Increase Degeneration of Hippocampal Neurons through Release of Tumor Necrosis Factor-α
Viviani, B., Corsini, E., Galli, C. L., & Marinovich, M. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8406 · Cited by 128 · cited 1×
“In fact, neurons exposed to trimethyltin, a toxin that induces neuronal apoptosis,(45) release as yet unidentified factors that stimulate inflammatory TNF production by glial cells that, in turn, amplifies neurotoxicity.(46) In this”
BackgroundLeverrier, Y., Thomas, J., Mathieu, A., Low, W., Blanquier, B., & Marvel, J. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400492 · Cited by 108 · cited 1×
“This PI3K–Akt pathway also leads to upregulation of Bcl-xL and inhibition of apoptosis in Baf-3 cells.(29) A further mechanism could be represented by NF-kB that is also a”
BackgroundHIF and oxygen sensing; as important to life as the air we breathe?
Wiesener, M. S., & Maxwell, P. H. (2003) · Annals of Medicine · doi:10.1080/0785389031000458233 · Cited by 104
Apoptosis and hematopoiesis in murine fetal liver
Yu, H., Bauer, B., Lipke, G., Phillips, R., & Van Zant, G. (1993) · Blood · doi:10.1182/blood.v81.2.373.373 · Cited by 102
Organotin compounds induce calcium overload and apoptosis in PC12 cells.
Viviani, B., Rossi, A. D., Chow, S. C., & Nicotera, P. (1995) · PubMed · Cited by 88
Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage.
Grasso, G. (2001) · PubMed · Cited by 83
Sekiguchi, Y., Kikuchi, S., Myers, R. R., & Campana, W. M. (2003) · Spine · doi:10.1097/01.brs.0000096674.12519.12 · Cited by 79 · cited 3×
“Campana et al.(66,67) performed a crush injury of a spinal nerve root for which follow-up showed a robust effect by EPO to prevent apoptosis in dorsal root ganglion neurons which”
BackgroundMethodBuemi, M., Vaccaro, M., Sturiale, A., Galeano, M. R., Sansotta, C., Cavallari, V., Floccari, F., D'Amico, D., Torre, V., Calapai, G., et al. (2002) · Acta Dermato-Venereologica · doi:10.1080/000155502762064520 · Cited by 77 · cited 1×
“The skin has also been shown to be protected by EPO in rodent flap models.(76,77) In these studies, the tissue-protective”
BackgroundProtective effect of erythropoietin in neonatal hypoxic ischemia in mice
Matsushita, H., Johnston, M. V., Lange, M. S., & Wilson, M. A. (2003) · NeuroReport · doi:10.1097/00001756-200309150-00020 · Cited by 76 · cited 1×
“eactivity in neurons in the injured areas was not decreased by EPO, neither was its subcellular distribution, despite a marked neuroprotective effect.(68)”
BackgroundBoyer, S. H., Bishop, T. R., Rogers, O., Noyes, A., Frelin, L. P., & Hobbs, S. (1992) · Blood · doi:10.1182/blood.v80.10.2503.2503 · Cited by 75 · cited 1×
“survival and therefore enabling the proliferation and differentiation of erythroid progenitor cells.(13,14) Although EPO, through the EPOR, can effectively support the proliferation of murine erythroid progenitor cells ex vivo(15) and induce the entry of erythroid progenitors into cell cycle if dormant,(16)”
BackgroundChan, A., Seguin, R., Magnus, T., Papadimitriou, C., Toyka, K. V., Antel, J. P., & Gold, R. (2003) · Glia · doi:10.1002/glia.10258 · Cited by 74
De Simone, R., Ajmone-Cat, M. A., Tirassa, P., & Minghetti, L. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.2.208 · Cited by 72 · cited 2×
“,(42) De Simone et al.(43) and Brouckaert et al.”
BackgroundKurosaka, K., Watanabe, N., & Kobayashi, Y. (2001) · Cellular Immunology · doi:10.1006/cimm.2001.1824 · Cited by 71 · cited 1×
“inflammatory cytokines by tissue macrophages during phagocytosis of apoptotic cells.(50,51) Similarly to what is observed in a model of cerebral ischemia with EPO,(40) inhibition of”
BackgroundErythropoietin Inhibits Calcium-Induced Neurotransmitter Release from Clonal Neuronal Cells
Kawakami, M., Iwasaki, S., Sato, K., & Takahashi, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3926 · Cited by 67
de Vries, B., Matthijsen, R. A., van Bijnen, A. A. J. H. M., Wolfs, T. G. A. M., & Buurman, W. A. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63629-2 · Cited by 60 · cited 1×
“apoptosis by lysophosphatidic acid or caspase inhibitors decreases inflammation in models of ischemic injury in the kidney and the brain.(52,53)”
BackgroundEid, T., Brines, M. L., Cerami, A., Spencer, D. D., Kim, J. H., Schweitzer, J. S., Ottersen, O. P., & De Lanerolle, N. C. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.1.73 · Cited by 60
Self-citationErythropoietin induces changes in gene expression in PC-12 cells
Renzi, M. J., Farrell, F. X., Bittner, A., Galindo, J. E., Morton, M., Trinh, H., & Jolliffe, L. K. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00323-6 · Cited by 57
Mogensen, J., Miskowiak, K. W., Sørensen, T. A., Lind, C., Olsen, N. V., Springborg, J. B., & Malá, H. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.017 · Cited by 55 · cited 1×
“In addition, it could explain the effects of EPO in reducing seizure severity(10) as well as reported effects on learning and memory.(57) Other”
BackgroundAkısü, M., Girgin, F. K., Baka, M., Hüseyinov, A., & Kültürsay, N. (2001) · European Journal of Pediatric Surgery · doi:10.1055/s-2001-15485 · Cited by 55
Akısü, M., Tüzün, S., Arslanoglu, S., Yalaz, M., & Kültürsay, N. (2001) · PubMed · doi:10.18926/amo/31997 · Cited by 51
Saray, A., Ozakpinar, R., Koç, C., Serel, S., Şen, Z. B., & Can, Z. (2003) · The Laryngoscope · doi:10.1097/00005537-200301000-00016 · Cited by 31 · cited 1×
“The skin has also been shown to be protected by EPO in rodent flap models.(76,77) In these studies, the tissue-protective”
BackgroundMiller, C. P., Liu, Z. Y., Noguchi, C. T., & Wojchowski, D. M. (1999) · Blood · doi:10.1182/blood.v94.10.3381.422k25_3381_3387 · Cited by 30
Romsi, P., Rönkä, E., Kiviluoma, K. T., Vainionpää, V., Hirvonen, J., Mennander, A., Pokela, M., Biancari, F., Rimpiläinen, J., & Juvonen, T. S. (2002) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2002.123704 · Cited by 25
Baron, F., Frère, P., Fillet, G., & Beguin, Y. P. (2003) · PubMed · Cited by 17
Cited by
Brines, M., Grasso, G., Fiordaliso, F., Sfacteria, A., Ghezzi, P., Fratelli, M., Latini, R., Xie, Q.-W., Smart, J., Su-Rick, C.-J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406491101 · Cited by 656
Self-citationTraumatic Brain Injury: Current Treatment Strategies and Future Endeavors
Galgano, M., Toshkezi, G., Qiu, X., Russell, T., Chin, L., & Zhao, L.-R. (2017) · Cell Transplantation · doi:10.1177/0963689717714102 · Cited by 582
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“[1968] Ghezzi, P.”
Emerging biological roles for erythropoietin in the nervous system
Brines, M., & Cerami, A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1687 · Cited by 523
Self-citationVollmar, B., & Menger, M. D. (2009) · Physiological Reviews · doi:10.1152/physrev.00027.2008 · Cited by 500
Metadata
- Authors
- Ghezzi, P., & Brines, M.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Oswego Community Hospital (US)
- Corresponding author
- Ghezzi, P
- Venue
- Cell Death & Differentiation
- Published
- 2004-07
- Volume
- 11
- Issue
- S1
- Pages
- S37-S44
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2121188367
- Cited by
- 327
- References
- 94
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 6 · 2023: 9 · 2022: 11 · 2021: 12 · 2020: 14 · 2019: 11 · 2018: 13 · 2017: 12 · 2016: 9 · 2015: 7 · 2014: 18 · 2013: 15 · 2012: 18
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research information system (University of Urbino) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Keywords
- erythropoietin, neuroprotection, neuronal apoptosis, signaling pathways, erythroid progenitor cells, tissue protection, bone marrow erythropoiesis
- MeSH terms
- Animals, Anti-Inflammatory Agents, DNA-Binding Proteins, Epithelial Cells, Erythropoietin, Hematopoiesis, Humans, Inflammation, Kidney Tubules, Models, Biological, Neurons, Nuclear Proteins, Transcription Factors, Signal Transduction, Cytokines, Myocardial Ischemia, Apoptosis, Neuroprotective Agents, Cytoprotection, Trauma, Nervous System, Endothelial Cells, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.